Neurology Main > Neuroimmunology & Multiple Sclerosis
ln

FAQ
Glossary
Research
- Clinical Trials
Treatment
- Cyclophosphamide (Cytoxan)
- First Line Disease Modifying Therapies
- Intravenous Immunoglobulin (IVIG)
- Methotrexate
- Mitoxantrone (Novantrone)
- Natalizumab (Tysabri)
- Rituximab (Rituxan)
- Solu-Medrol

Appointments and Referrals

Faculty
- Jaime Imitola, MD
- D. Joanne Lynn, MD
- Michael Racke, MD
Infusion Nurses
- Cynthia Hunter, RN
- Nancy, Ficco, RN
Research Staff
- Misty Regula
- Stephanie Scarberry, RN

Contact us at 614.293.4969

Neuroimmunology and Multiple Sclerosis
ln

Multiple sclerosis (MS) is a chronic disease of the central nervous system. It is an unpredictable condition that can be relatively benign, disabling, or devastating. Our comprehensive program of clinical services is supported by basic and clinical research. Our physician-scientists have gained national recognition in improving treatment options for multiple sclerosis patients. Currently, the OSU Multiple Sclerosis Clinic is one of the largest MS Centers in the country with more than 4,000 patients. To learn more about MS, select from the links to your left or contact the OSU Department of Neurology at (614) 293-4969